# A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Abdominal Surgery

> **NCT07533786** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Haisco Pharmaceutical Group Co., Ltd.** · enrollment: 200 (estimated)

## Conditions studied

- Pain After Surgery

## Interventions

- **DRUG:** HSK55718 dose level1
- **DRUG:** HSK55718 dose level2
- **DRUG:** HSK55718 dose level 3
- **DRUG:** Placebo control
- **DRUG:** morphine

## Key facts

- **NCT ID:** NCT07533786
- **Lead sponsor:** Haisco Pharmaceutical Group Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-20
- **Primary completion:** 2027-04-20
- **Final completion:** 2027-04-20
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07533786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07533786, "A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Abdominal Surgery". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07533786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*